Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications

MLA

James M. Richter, et al. “Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Jan. 2016. EBSCOhost, https://doi.org/10.1155/2016/6928710.

APA

James M. Richter, Nabeela K. Arshi, & Gerry Oster. (2016). Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications. Canadian Journal of Gastroenterology and Hepatology, 2016. https://doi.org/10.1155/2016/6928710

Chicago

James M. Richter, Nabeela K. Arshi, and Gerry Oster. 2016. “Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.” Canadian Journal of Gastroenterology and Hepatology 2016 (January). doi:10.1155/2016/6928710.